Trump's latest tariff threat has European leaders plotting response
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
20 minutes ago
- Globe and Mail
Elevance to Report Q2 Earnings: Will Rising Costs Pressure Profits?
Elevance Health, Inc. ELV is set to report its second-quarter 2025 results on July 17, 2025, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter's earnings is currently pegged at $9.20 per share on revenues of $48.13 billion. The second-quarter earnings estimate declined 1.8% over the past 60 days. The bottom-line projection indicates a year-over-year decline of 9.1%. However, the Zacks Consensus Estimate for quarterly revenues implies a year-over-year increase of 11.4%. For 2025, the Zacks Consensus Estimate for Elevance's revenues is pegged at $195 billion, implying a rise of 11.3% year over year. The consensus mark for 2025 EPS is pegged at $34.40, implying a 4.1% year-over-year increase. (See the Zacks Earnings Calendar to stay ahead of market-making news.) Elevance's earnings beat the consensus estimate in three of the trailing four quarters and missed once, with the average surprise being negative 1.2%. This is depicted in the figure below. Elevance Health, Inc. Price and EPS Surprise Q2 Earnings Whispers for Elevance Our proven model does not conclusively predict an earnings beat for the company this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. That is not the case here. ELV has an Earnings ESP of 0.00% and a Zacks Rank #3. You can uncover the best stocks to buy or sell before they're reported with our Earnings ESP Filter. What's Shaping Elevance's Q2 Results? The Zacks Consensus Estimate for product revenues indicates 11.1% growth from the year-ago period's $5.5 billion. The consensus estimate for premiums indicates an 11.9% increase from the year-ago period. These are likely to have aided revenues in the second quarter. The consensus mark for Commercial Individual membership implies 5.9% growth from a year ago, while our model estimate indicates a 5.6% increase. However, the consensus estimate for Commercial Fee-based memberships indicates a 0.1% year-over-year decline. Meanwhile, the Zacks Consensus Estimate for Carelon brand's operating income for the second quarter indicates a 14.1% year-over-year increase. Growth in CarelonRx is primarily expected to have aided the brand. The results are likely to have been supported by the recent buyouts in home health and pharmacy services. However, its expenses are likely to have remained elevated in the quarter due to substantial investments in digital capabilities and platforms. High benefit expenses, cost of products sold and interest expenses are likely to have affected profit margins, making earnings beat uncertain. The Zacks Consensus Estimate for the benefit expense ratio is pegged at 88.4, higher than the year-ago level of 86.3. We expect total expenses to jump nearly 11% year over year in the second quarter. The Zacks Consensus Estimate for the Health Benefits segment's operating income for the second quarter indicates a 12.4% year-over-year decrease. Also, declining memberships in Medicaid are likely to have kept second-quarter premium growth in check. Stocks That Warrant a Look While an earnings beat looks uncertain for Elevance, here are some companies from the broader Medical space that you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this time around: Boston Scientific Corporation BSX has an Earnings ESP of +0.88% and a Zacks Rank #2. You can see the complete list of today's Zacks #1 Rank stocks here. The Zacks Consensus Estimate for Boston Scientific's bottom line for the to-be-reported quarter indicates a 16.1% year-over-year growth. Boston Scientific's earnings beat estimates in each of the last four quarters, with an average surprise of 8.8%. CVS Health Corporation CVS has an Earnings ESP of +2.06% and a Zacks Rank of 2. The Zacks Consensus Estimate for CVS Health's bottom line for the to-be-reported quarter is pegged at $1.47. CVS Health's earnings beat estimates in each of the past four quarters, with an average surprise of 18.1%. Summit Therapeutics Inc. SMMT has an Earnings ESP of +6.25% and a Zacks Rank of 2. The Zacks Consensus Estimate for Summit Therapeutics' bottom line for the to-be-reported quarter has witnessed one upward estimate revision in the past 60 days with no opposite movement. Summit Therapeutics' earnings beat estimates in two of the trailing four quarters, met once and missed on the other occasion, with an average surprise of 3.1%. 5 Stocks Set to Double Each was handpicked by a Zacks expert as the favorite stock to gain +100% or more in the months ahead. They include Stock #1: A Disruptive Force with Notable Growth and Resilience Stock #2: Bullish Signs Signaling to Buy the Dip Stock #3: One of the Most Compelling Investments in the Market Stock #4: Leader In a Red-Hot Industry Poised for Growth Stock #5: Modern Omni-Channel Platform Coiled to Spring Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. While not all picks can be winners, previous recommendations have soared +171%, +209% and +232%. Download Atomic Opportunity: Nuclear Energy's Comeback free today. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Boston Scientific Corporation (BSX): Free Stock Analysis Report CVS Health Corporation (CVS): Free Stock Analysis Report Summit Therapeutics PLC (SMMT): Free Stock Analysis Report Elevance Health, Inc. (ELV): Free Stock Analysis Report
CTV News
25 minutes ago
- CTV News
Milwaukee man pleads guilty to carrying concealed pistol near Republican National Convention
MILWAUKEE — A Milwaukee man has pleaded guilty to carrying a concealed pistol outside the Republican National Convention's security perimeter last year. U.S. Federal agents stopped Donnell Tinsley as he was walking near the convention's security zone on the gathering's first day in July 2024, according to a criminal complaint. Tinsley was wearing black pants and a ski mask and was carrying what the complaint described as a black tactical backpack. Agents found an AK-47-style pistol in the backpack. The arrest came just two days after Thomas Matthew Crooks tried to assassinate U.S. President Donald Trump during a campaign appearance in Butler, Pennsylvania. Trump was a presidential candidate at the time and went on to capture the White House in the November elections. Online court records show Tinsley, now 22, pleaded guilty July 3 to a misdemeanor count of carrying a concealed weapon. Milwaukee County Circuit Judge Marisabel Cabrera, a former Democratic state representative, sentenced him to 26 days time served. Tinsley's attorney, public defender Elizabeth Ellsworth-Kasch, declined comment when reached by phone Monday. The Associated Press
Calgary Herald
27 minutes ago
- Calgary Herald
Border bitterness is devastating cross-border tourism. But one Canadian city is bucking the trend
Article content Those who travel by car between the U.S. and Canada at crossings like the Peace Bridge have grown accustomed to long wait times over the years, but drivers headed in either direction today rarely face delays. Article content Those empty lanes signal a stark change: Cross-border travel has fallen to historic lows, surpassing even the slowdowns seen after 9/11 and the 2008 financial crisis. Article content Article content 'We are currently seeing more extreme drops in travel by car than we did during those (earlier) crises,' says Laura Presley, an analyst at Statistics Canada, noting an 'abrupt shift' at the start of this year. Article content Article content Article content U.S. President Donald Trump's trade war, his '51st state' rhetoric, and stricter immigration rules have sparked a backlash that has Canadians choosing to spend more at home, and less on American goods and travel. Article content Americans, in turn, are less sure about being welcome up north, and everyone is dealing with economic uncertainty. Article content It hasn't been easy. Article content After 9/11, car travel to the U.S. by Canadian residents dropped by just over 30 per cent, and the 2008 financial crisis saw car travel drop by just under 23 per cent. Data released last week show this is worse than both: Canadian return trips from the U.S. by car in June dropped 33.1 per cent compared to June 2024, and that was the sixth consecutive month of decline. Canadian air travel to the U.S. also fell by 22.1 per cent in June. Article content Article content Canadians spent US$20.5 billion in the U.S. last year, and the U.S. Travel Association has warned that a 10 per cent drop in Canadian tourism this year could cost the American economy US$2.1 billion in spending and 140,000 jobs. Article content Article content Article content The trend has hurt Canada, too, but not as badly. American car trips to Canada in June fell 10.4 per cent year-over-year, for a fifth month of decline. American air travel to Canada is down too, but only by 0.7 per cent in June. Article content Anusha Arif, an economist at TD Economics, said her research points to a decline of up to 10 per cent in U.S. spending in Canada, which could add up to a $1-billion loss.
